These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2699660)

  • 1. Ependymomas in two sisters and a maternal male cousin with mosaicism with monosomy 22 in tumour.
    Savard ML; Gilchrist DM
    Pediatr Neurosci; 1989; 15(2):80-4. PubMed ID: 2699660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial anaplastic ependymoma: evidence of loss of chromosome 22 in tumour cells.
    Nijssen PC; Deprez RH; Tijssen CC; Hagemeijer A; Arnoldus EP; Teepen JL; Holl R; Niermeyer MF
    J Neurol Neurosurg Psychiatry; 1994 Oct; 57(10):1245-8. PubMed ID: 7931388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma.
    Weremowicz S; Kupsky WJ; Morton CC; Fletcher JA
    Cancer Genet Cytogenet; 1992 Jul; 61(2):193-6. PubMed ID: 1638502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of a putative low-penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling-path genomic microarray.
    Ammerlaan AC; de Bustos C; Ararou A; Buckley PG; Mantripragada KK; Verstegen MJ; Hulsebos TJ; Dumanski JP
    Genes Chromosomes Cancer; 2005 Aug; 43(4):329-38. PubMed ID: 15880457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal composition of a series of 22 human low-grade gliomas.
    Rey JA; Bello MJ; de Campos JM; Kusak ME; Moreno S
    Cancer Genet Cytogenet; 1987 Dec; 29(2):223-37. PubMed ID: 3677044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cytogenetic studies of pediatric ependymomas.
    Kramer DL; Parmiter AH; Rorke LB; Sutton LN; Biegel JA
    J Neurooncol; 1998 Mar; 37(1):25-33. PubMed ID: 9525835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial subependymomas.
    Honan WP; Anderson M; Carey MP; Williams B
    Br J Neurosurg; 1987; 1(3):317-21. PubMed ID: 3268127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Karyotypes in 90 human gliomas.
    Thiel G; Losanowa T; Kintzel D; Nisch G; Martin H; Vorpahl K; Witkowski R
    Cancer Genet Cytogenet; 1992 Feb; 58(2):109-20. PubMed ID: 1551072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome aberrations in four ependymomas.
    Sawyer JR; Sammartino G; Husain M; Boop FA; Chadduck WM
    Cancer Genet Cytogenet; 1994 Jun; 74(2):132-8. PubMed ID: 8019957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an
    Mangum R; Reuther J; Bertrand KC; Chandramohan R; Kukreja MK; Paulino AC; Muzny D; Hu J; Gibbs RA; Curry DJ; Malbari F; Chintagumpala MM; Adesina AM; Fisher KE; Mack SC; Plon SE; Roy A; Parsons DW; Lin FY
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34651095
    [No Abstract]   [Full Text] [Related]  

  • 11. Loss of heterozygosity on chromosome 22 in human ependymomas.
    Huang B; Starostik P; Kühl J; Tonn JC; Roggendorf W
    Acta Neuropathol; 2002 Apr; 103(4):415-20. PubMed ID: 11904762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaplastic ependymomas: clinical features and tumour suppressor gene p53 analysis.
    Tominaga T; Kayama T; Kumabe T; Sonoda Y; Yoshimoto T
    Acta Neurochir (Wien); 1995; 135(3-4):163-70. PubMed ID: 8748809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas.
    Ransom DT; Ritland SR; Kimmel DW; Moertel CA; Dahl RJ; Scheithauer BW; Kelly PJ; Jenkins RB
    Genes Chromosomes Cancer; 1992 Nov; 5(4):348-56. PubMed ID: 1283324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of chromosome 1 in myxopapillary ependymoma suggests a region out of chromosome 22 as critical for tumour biology: a FISH analysis of four cases on touch imprint smears.
    Tamiolakis D; Papadopoulos N; Venizelos I; Lambropoulou M; Nikolaidou S; Bolioti S; Kiziridou A; Manavis J; Alexiadis G; Simopoulos C
    Cytopathology; 2006 Aug; 17(4):199-204. PubMed ID: 16879268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic abnormalities in oligodendroglial and ependymal tumours.
    Goussia AC; Kyritsis AP; Mitlianga P; Bruner JM
    J Neurol; 2001 Dec; 248(12):1030-5. PubMed ID: 12013578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of chromosome 22 in ependymomas.
    Wernicke C; Thiel G; Lozanova T; Vogel S; Kintzel D; Jänisch W; Lehmann K; Witkowski R
    Cancer Genet Cytogenet; 1995 Feb; 79(2):173-6. PubMed ID: 7889515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
    Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
    Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2.
    Hulsebos TJ; Oskam NT; Bijleveld EH; Westerveld A; Hermsen MA; van den Ouweland AM; Hamel BC; Tijssen CC
    Br J Cancer; 1999 Dec; 81(7):1150-4. PubMed ID: 10584875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic abnormalities in human ependymomas.
    Stratton MR; Darling J; Lantos PL; Cooper CS; Reeves BR
    Int J Cancer; 1989 Oct; 44(4):579-81. PubMed ID: 2793229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytophotometric investigations of the nuclear DNA content in ependymomas and plexuspapillomas (author's transl)].
    Müller W; Brämisch R; Afra D; Schwenzfeger A
    Acta Neuropathol; 1977 Aug; 39(3):255-9. PubMed ID: 906808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.